Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mai Takeuchi

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
International Journal of Clinical Oncology|April 12, 2026
Real-world outcomes of chimeric antigen receptor T-cell therapy with pembrolizumab as holding and/or bridging therapy in relapsed/refractory primary mediastinal large B-cell lymphomaRisa Nishiyama, Shinichi Makita, Anna Hiratsuka, et al.
European Journal of Pediatrics|October 31, 2013
The emergence of CD20-/CD19- tumor cells after rituximab therapy for Epstein-Barr virus-associated post-transplant lymphoproliferative disorder complicated with hemophagocytic lymphohistiocytosisNobuyuki Yamamoto, Noriyuki Nishimura, Mai Takeuchi, et al.
Internal Medicine (Tokyo, Japan)|September 21, 2022
Diffuse Large B-cell Lymphoma Involving an Abundant Infiltration of T Follicular Helper CellsKeitaro Ishii, Kazuharu Kamachi, Sho Okamoto, et al.
Cancer Science|April 29, 2020
Combination of CD47 and signal-regulatory protein-α constituting the "don't eat me signal" is a prognostic factor in diffuse large B-cell lymphomaRyo Kazama, Hiroaki Miyoshi, Mai Takeuchi, et al.
Cancer Immunology, Immunotherapy : CII|September 12, 2016
Regulatory T cells function at the early stage of tumor progression in a mouse model of tongue squamous cell carcinomaKentaro Miki, Yorihisa Orita, Yuka Gion, et al.
Pathology, Research and Practice|January 23, 2024
Co-expression of regulatory B-cell markers, transforming growth factor β and interleukin-10 as a prognostic factor in diffuse large B-cell lymphomaTatsuzo Mishina, Hiroaki Miyoshi, Mai Takeuchi, et al.
JNCI Cancer Spectrum|April 11, 2026
Microbiomic and immunogenic biomarkers of adjuvant chemotherapy efficacy in stage III colorectal cancerErika Machida, Yasuyuki Takamizawa, Daisuke Takayanagi, et al.
Cancer Medicine|January 18, 2024
Clinicopathological comparison between PTCL-TBX21 and PTCL-GATA3 in Japanese patientsYasumasa Shimasaki, Hiroaki Miyoshi, Keisuke Kawamoto, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|May 31, 2020
Deep learning shows the capability of high-level computer-aided diagnosis in malignant lymphomaHiroaki Miyoshi, Kensaku Sato, Yoshinori Kabeya, et al.
Medical Image Analysis|January 30, 2023
Case-based similar image retrieval for weakly annotated large histopathological images of malignant lymphoma using deep metric learningNoriaki Hashimoto, Yusuke Takagi, Hiroki Masuda, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
International Journal of Clinical Oncology|April 12, 2026
Real-world outcomes of chimeric antigen receptor T-cell therapy with pembrolizumab as holding and/or bridging therapy in relapsed/refractory primary mediastinal large B-cell lymphomaRisa Nishiyama, Shinichi Makita, Anna Hiratsuka, et al.
European Journal of Pediatrics|October 31, 2013
The emergence of CD20-/CD19- tumor cells after rituximab therapy for Epstein-Barr virus-associated post-transplant lymphoproliferative disorder complicated with hemophagocytic lymphohistiocytosisNobuyuki Yamamoto, Noriyuki Nishimura, Mai Takeuchi, et al.
Internal Medicine (Tokyo, Japan)|September 21, 2022
Diffuse Large B-cell Lymphoma Involving an Abundant Infiltration of T Follicular Helper CellsKeitaro Ishii, Kazuharu Kamachi, Sho Okamoto, et al.
Cancer Science|April 29, 2020
Combination of CD47 and signal-regulatory protein-α constituting the "don't eat me signal" is a prognostic factor in diffuse large B-cell lymphomaRyo Kazama, Hiroaki Miyoshi, Mai Takeuchi, et al.
Cancer Immunology, Immunotherapy : CII|September 12, 2016
Regulatory T cells function at the early stage of tumor progression in a mouse model of tongue squamous cell carcinomaKentaro Miki, Yorihisa Orita, Yuka Gion, et al.
Pathology, Research and Practice|January 23, 2024
Co-expression of regulatory B-cell markers, transforming growth factor β and interleukin-10 as a prognostic factor in diffuse large B-cell lymphomaTatsuzo Mishina, Hiroaki Miyoshi, Mai Takeuchi, et al.
JNCI Cancer Spectrum|April 11, 2026
Microbiomic and immunogenic biomarkers of adjuvant chemotherapy efficacy in stage III colorectal cancerErika Machida, Yasuyuki Takamizawa, Daisuke Takayanagi, et al.
Cancer Medicine|January 18, 2024
Clinicopathological comparison between PTCL-TBX21 and PTCL-GATA3 in Japanese patientsYasumasa Shimasaki, Hiroaki Miyoshi, Keisuke Kawamoto, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|May 31, 2020
Deep learning shows the capability of high-level computer-aided diagnosis in malignant lymphomaHiroaki Miyoshi, Kensaku Sato, Yoshinori Kabeya, et al.
Medical Image Analysis|January 30, 2023
Case-based similar image retrieval for weakly annotated large histopathological images of malignant lymphoma using deep metric learningNoriaki Hashimoto, Yusuke Takagi, Hiroki Masuda, et al.
Pageof 8